[Federal Register: December 29, 2008 (Volume 73, Number 249)]
[Notices]               
[Page 79490-79491]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29de08-71]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60-Day-09-09AI]

 
Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 or 
send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance 
Officer, 1600 Clifton Road, MS D-74, Atlanta, GA 30333 or send an e-
mail to omb@cdc.gov.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Evaluation of the Action Plan for the National Public Health 
Initiative on Diabetes and Women's Health--New--National Center for 
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    Approximately 24 million Americans have diabetes, and more than 9 
million of these individuals are women. It is projected that from 2000 
to 2025, women will represent more than half of all cases of diabetes 
in the United States.
    Diabetes can have unique and profound effects on women's lives and 
health. For instance, diabetes is a more common cause of coronary heart 
disease among women than men. In addition, among people with diabetes, 
the prognosis of heart disease is worse for women than men, with women 
having poorer quality of life and lower survival rates. The burden of 
diabetes for women is also unique because the disease can affect 
mothers and their unborn children. After pregnancy, as many as 10-50% 
of women with gestational diabetes mellitus (GDM) are diagnosed with 
type 2 diabetes within five years of delivery. The offspring of women 
with a history of gestational diabetes are also at risk for becoming 
obese during childhood or adolescence, which may increase their risk of 
developing type 2 diabetes later in life.
    To address the burden of diabetes on women's health, the National 
Public Health Initiative on Diabetes and Women's Health (``The 
Initiative'') was established to provide support and resources for the 
creation and implementation of a national public health Action Plan. 
The Initiative is co-sponsored by the American Diabetes Association 
(ADA), the American Association of Diabetes Educators (AADE), the 
American Public Health Association (APHA), the Association of State and 
Territorial Health Officials (ASTHO), and the Centers for Disease 
Control and Prevention (CDC). CDC's Division of Diabetes Translation is 
dedicated to the prevention and control of diabetes, and to reducing or 
eliminating health disparities through targeted research, programs, and 
partnerships.
    The Initiative's Action Plan identifies gaps in diabetes-related 
research and programmatic activities, and strategic objectives, within 
the areas of: (1) Community health; (2) diabetes state programs; (3) 
education and community outreach; (4) quality of care; (5) research; 
and (6) surveillance. Co-sponsors of the Initiative and other partner 
organizations have been encouraged to act on the deficiencies

[[Page 79491]]

and priorities identified in the Action Plan.
    CDC proposes to conduct a survey to assess collective progress 
toward achieving the objectives outlined in the Action Plan. The survey 
will also request information about the specific strategies, steps, 
resources and partnerships that have been employed to meet the 
objectives. Respondents will be the 4 co-sponsors of The Initiative, 51 
CDC-funded, state-based diabetes prevention and control programs, and 
approximately 230 private-sector public health organizations with a 
focus on diabetes and/or women's health. Survey responses will be 
compiled into a report and disseminated to respondents, allowing them 
to learn about each other's activities and the steps needed to 
replicate successful diabetes prevention and control efforts.
    Because organizations are in various stages of Action Plan 
implementation, information will be collected once per year for a 
period of 3 years, and the report will be updated annually to reflect 
recent activities and progress. Private-sector partners will submit one 
survey response per organization per year. Co-sponsors will receive a 
modified version of the survey. Due to the size and complexity of the 
activities managed by co-sponsors, the co-sponsoring organizations will 
have the option to submit multiple survey responses from different 
areas of the organization, in order to capture the full range of 
activities conducted. It is estimated that each co-sponsor will submit 
an average of three responses.
    Information will be collected electronically through web-based 
surveys. There are no costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent       (in hrs)        (in hrs)
----------------------------------------------------------------------------------------------------------------
Co-Sponsors...................  Co-Sponsor                     4               3           30/60               6
                                 Survey.
State and Local Govt. Partners  Partner Survey..              51               1           30/60              26
Private Sector Partners.......                               230               1           30/60             115
                                                 ---------------------------------------------------------------
    Total.......................................  ..............  ..............  ..............             147
----------------------------------------------------------------------------------------------------------------


    Dated: December 18, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
 [FR Doc. E8-30771 Filed 12-24-08; 8:45 am]

BILLING CODE 4163-18-P